Jeil Pharmaceutical Co.,Ltd
Jeil Pharmaceutical Co.,Ltd (KRX: 271980) is trading at ₩10,050.00, about ₹725 at today's KRW/INR rate, as of 8 Oct 2026, 2:30 AM ET, down 2.71% today. Jeil Pharmaceutical is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.
Quote
Today's low
₩9,980.00
Today's high
₩10,330.00
52 week low
₩8,810.00
52 week high
₩19,290.00
271980 opened at ₩10,330.00, closed previously at ₩10,330.00, and has traded between ₩8,810.00 and ₩19,290.00 over the past 52 weeks.
About
Primarily active within South Korea, Jeil Pharmaceutical Co.,Ltd dedicates itself to the development and supply of a broad spectrum of pharmaceutical goods. Its product offerings address numerous therapeutic categories, including antibiotics, gastrointestinal health, cardiovascular conditions, neuropsychiatric disorders, cancer (oncology), endocrine imbalances, urological issues, viral infections, and antihistamine remedies. Furthermore, the company extends its market reach globally, exporting its merchandise to roughly 40 nations across the ASEAN bloc, Central and South America, Africa, and other international destinations. Founded in 1959, Jeil Pharmaceutical Co.,Ltd maintains its headquarters in Seoul, South Korea.
Key statistics
Avg. volume
55.13K
Market cap
₩147.78B
P/E Ratio
8.27
Price-to-sales ratio
0.27
Enterprise value
₩267.32B
Free cash flow yield
-6.16%
Debt-to-equity ratio
0.55
Return on equity
11.08%
ROIC
5.16%
Beta
1.53
Dividend yield
0.00%
Last dividend
₩0.00
Financial overview
Revenue
₩566.34B
Earnings per share
₩1,604.77
Free cash flow
-₩13.72B
Net profit margin
1.71%
Gross margin
39.07%
EBITDA
₩32.65B
Revenue growth
-19.62%
Similar securities
This is not an investment recommendation
Jeil Pharmaceutical for Indian investors
Jeil Pharmaceutical is listed on the Korea Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.
Taxes on Jeil Pharmaceutical for Indian residents
Trading and limits
- Trading hours
- 9:00 am – 3:30 pm KST
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneJeil Pharmaceutical does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
FAQs
Can I buy Jeil Pharmaceutical on Paasa?
Jeil Pharmaceutical (271980) has been listed on the Korea Exchange since 2017, in the Drug Manufacturers - Specialty & Generic industry. Jeil Pharmaceutical is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.
How much does one Jeil Pharmaceutical share cost in rupees?
One Jeil Pharmaceutical share is ₩10,050.00 — about ₹725 at a KRW/INR rate of 0.0722 on 8 Oct 2026. Both the Jeil Pharmaceutical price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for investing abroad from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.
How are gains on Jeil Pharmaceutical shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the KRW/INR rate on the purchase and the sale date, so the rupee move counts alongside the Jeil Pharmaceutical price.
Does Jeil Pharmaceutical pay a dividend?
No. Jeil Pharmaceutical does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one: dividends are taxed at your slab rate in India.
When does KRX trade, in Indian time?
The Korea Exchange trades 5:30 am – 12:00 pm IST in Indian time.
Do I have to declare Jeil Pharmaceutical shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.
Does the rupee rate affect what I make on Jeil Pharmaceutical?
Yes. Jeil Pharmaceutical is priced in KRW, so your rupee outcome combines the KRW move with the KRW/INR move between the day you remit and the day you convert back.